Treatment of Early Hypertension Among Persons Living With HIV in Haiti

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT04692467

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04692467
Other papers using this trial's data
  • Treatment of prehypertension among adults with HIV AIDS (London, England), 2025-03-01 DOI, PubMed 39761592, PMC11779584 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Haiti (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04692467. Randomized; no masking; primary purpose treatment. Start 2021-02-26 (actual); primary completion 2023-06-30 (actual). Results posted on 2024-04-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
Condition
HIV/AIDS
Condition
Pre Hypertension
Intervention (Drug)
Amlodipine 5mg
Lead sponsor
Weill Medical College of Cornell University (class: other)
Collaborator
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic (class: other)
Collaborator
Fogarty International Center of the National Institute of Health (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04692467
Content hash
dd6f660cd0f368d765e8ce5172881ecfdbeaf73289b70d302d9f932b378006be